Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX

Vertex Pharmaceuticals (VRTX) Stock Forecast & Price Target

4,316 Followers
See the Price Targets and Ratings of:

VRTX Analyst Ratings

Moderate Buy
19Ratings
12 Buy
7 Hold
0 Sell
Based on 19 analysts giving stock ratings to
Vertex
Pharmaceuticals
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

VRTX Stock 12 Months Forecast

Average Price Target

$322.06
▲(3.15% Upside)
Based on 19 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $322.06 with a high forecast of $442.00 and a low forecast of $265.00. The average price target represents a 3.15% change from the last price of $312.22.
Highest Price Target$442.00Average Price Target$322.06Lowest Price Target$265.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
Wells Fargo
$335.00
Buy
7.30%
Upside
Reiterated
Vertex Pharmaceuticals (VRTX) Receives a Buy from Wells Fargo
Needham
Hold
Reiterated
Needham Sticks to Their Hold Rating for Vertex Pharmaceuticals (VRTX)
Robert W. Baird
$280.00
Hold
-10.32%
Downside
Reiterated
Vertex Pharmaceuticals (VRTX) Gets a Hold from Robert W. Baird
Maxim Group
$325.00
Buy
4.09%
Upside
Assigned
Vertex Pharmaceuticals (VRTX) Receives a Buy from Maxim Group
H.C. Wainwright
$300.00
Buy
-3.91%
Downside
Reiterated
Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (NASDAQ: VRTX) and Vaccitech Plc (NASDAQ: VACC)
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
xxxxxxxxxxxxxxx
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

VRTX Financial Forecast

VRTX Earnings Forecast
Next quarter’s earnings estimate for VRTX is $3.60 with a range of $2.73 to $4.01. The previous quarter’s EPS was $4.01. VRTX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.50% of the time in the same period. In the last calendar year VRTX has Outperformed its overall industry.
Next quarter’s earnings estimate for VRTX is $3.60 with a range of $2.73 to $4.01. The previous quarter’s EPS was $4.01. VRTX beat its EPS estimate 75.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 52.50% of the time in the same period. In the last calendar year VRTX has Outperformed its overall industry.
VRTX Sales Forecast
Next quarter’s sales forecast for VRTX is $2.30B with a range of $2.21B to $2.40B. The previous quarter’s sales results were $2.27B. VRTX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 42.84% of the time in the same period. In the last calendar year VRTX has Outperformed its overall industry.
Next quarter’s sales forecast for VRTX is $2.30B with a range of $2.21B to $2.40B. The previous quarter’s sales results were $2.27B. VRTX beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 42.84% of the time in the same period. In the last calendar year VRTX has Outperformed its overall industry.
VRTX Analyst Recommendation Trends
In the current month, VRTX has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The VRTX average analyst price target in the past 3 months is $322.06
In the current month, VRTX has received 0 Buy ratings 1 Hold ratings, and 0 Sell ratings. The VRTX average analyst price target in the past 3 months is $322.06

VRTX Stock Forecast FAQ

What is VRTX’s average 12-month price target, according to analysts?
Based on analyst ratings, Vertex Pharmaceuticals’s 12-month average price target is $322.06.
    What is VRTX’s upside potential, based on the analysts’ average price target?
    Vertex Pharmaceuticals has 3.15% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is VRTX a Buy, Sell or Hold?
          Vertex Pharmaceuticals has a conensus rating of Moderate Buy which is based on 12 buy ratings, 7 hold ratings and 0 sell ratings.
            What is Vertex Pharmaceuticals’s price target?
            The average price target for Vertex Pharmaceuticals is $322.06. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $442.00 ,the lowest forecast is $265.00. The average price target represents 3.15% Increase from the current price of $312.22.
              What do analysts say about Vertex Pharmaceuticals?
              Vertex Pharmaceuticals’s analyst rating consensus is a ‘Moderate Buy. This is based on the ratings of 19 Wall Streets Analysts.

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis